Search for Clinical Trial Results
Anaplastic Oligodendroglioma - 228 Studies Found
Status | Study |
Terminated |
Study Name: Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma Condition:
Interventions: |
Completed |
Study Name: AZD8055 for Adults With Recurrent Gliomas Condition:
|
Completed |
Study Name: BIBF 1120 for Recurrent High-Grade Gliomas Condition:
Interventions: Drug: BIBF 1120 200 mg BID oral for 28 day cycle |
Terminated |
Study Name: (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas Condition:
|
Completed |
Study Name: A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas Condition:
|
Completed |
Study Name: Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors Condition:
Interventions: |
Completed |
Study Name: Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma Condition:
|
Withdrawn |
Study Name: Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors Condition:
|
Completed |
Study Name: VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide Condition:
|
Completed |
Study Name: Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma Condition:
|